Investment
Features
FeesSafety
Academy
More
Pluang+

Compare MGM Resorts International (MGM) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance

MGM Resorts InternationalTrade
State Street SPDR S&P Biotech ETFTrade

Price performance (Past 24H)

Key statistics

MGM Resorts International vs State Street SPDR S&P Biotech ETF — how do they compare? MGM Resorts International trades at $46.57 (market cap $11.86B), while State Street SPDR S&P Biotech ETF trades at $154.46. The key difference: MGM Resorts International pays a 0.03% dividend while State Street SPDR S&P Biotech ETF pays none. Which is the better fit depends on your goals.

MGMXBI
Market Cap
$11.86B
Sector
Consumer CyclicalBroad Market / Factor
52-Week High
$50.69$164.28
52-Week Low
$30.72$85.16
Enterprise Value
$40.90B
Dividend Yield
0.03%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About MGM Resorts International

MGM Resorts is the largest resort operator on the Las Vegas Strip with 35,000 guest rooms and suites, representing about one fourth of all units in the market. The company's Vegas properties include MGM Grand, Mandalay Bay, Cosmopolitan, Luxor, New York-New York, and CityCenter. The Strip contributed approximately 49% of total EBITDAR in the prepandemic year of 2019. MGM also owns U.S. regional assets, which represented 29% of 2019 EBITDAR. we estimate MGM's U.S. sports and iGaming operations are currently a mid-single-digit percentage of its total revenue. The company also operates the 56%-owned MGM Macau casinos with a new property that opened on the Cotai Strip in early 2018. Further, we estimate MGM will open a resort in Japan in 2027.

Read more on MGM

About State Street SPDR S&P Biotech ETF

XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.

Read more on XBI